Business Description
Alector Inc
NAICS : 325412
SIC : 2834
ISIN : US0144421072
Description
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 13.2 | |||||
| Equity-to-Asset | 0.23 | |||||
| Debt-to-Equity | 0.29 | |||||
| Debt-to-EBITDA | -0.2 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Altman Z-Score | -1.98 | |||||
| Beneish M-Score | -3.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 62.3 | |||||
| 3-Year EBITDA Growth Rate | 11 | |||||
| 3-Year EPS without NRI Growth Rate | 14 | |||||
| 3-Year FCF Growth Rate | -0.3 | |||||
| 3-Year Book Growth Rate | -22.3 | |||||
| Future 3-5Y Total Revenue Growth Rate | 18.77 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 15.11 | |||||
| 9-Day RSI | 22.18 | |||||
| 14-Day RSI | 27.77 | |||||
| 6-1 Month Momentum % | -1.73 | |||||
| 12-1 Month Momentum % | -7.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.29 | |||||
| Quick Ratio | 3.29 | |||||
| Cash Ratio | 3.21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.3 | |||||
| Shareholder Yield % | -26.11 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -301.1 | |||||
| Net Margin % | -257.54 | |||||
| FCF Margin % | -361.69 | |||||
| ROE % | -106.3 | |||||
| ROA % | -26.26 | |||||
| ROIC % | -109.02 | |||||
| ROC (Joel Greenblatt) % | -413.84 | |||||
| ROCE % | -41.56 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.91 | |||||
| PB Ratio | 2.13 | |||||
| Price-to-Tangible-Book | 2.15 | |||||
| EV-to-EBIT | 0.91 | |||||
| EV-to-EBITDA | 0.96 | |||||
| EV-to-Revenue | -2.75 | |||||
| EV-to-Forward-Revenue | 0.73 | |||||
| EV-to-FCF | 0.76 | |||||
| Price-to-Net-Current-Asset-Value | 3.52 | |||||
| Price-to-Net-Cash | 4.22 | |||||
| Earnings Yield (Greenblatt) % | 109.89 | |||||
| FCF Yield % | -87.63 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Alector Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 56.386 | ||
| EPS (TTM) (€) | -1.558 | ||
| Beta | 1.01 | ||
| Volatility % | 74.03 | ||
| 14-Day RSI | 27.77 | ||
| 14-Day ATR (€) | 0.31112 | ||
| 20-Day SMA (€) | 4.0055 | ||
| 12-1 Month Momentum % | -7.72 | ||
| 52-Week Range (€) | 2.32 - 7.9 | ||
| Shares Outstanding (Mil) | 97.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Alector Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Alector Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Alector Inc Frequently Asked Questions
What is Alector Inc(STU:0Z2)'s stock price today?
The current price of STU:0Z2 is €2.32. The 52 week high of STU:0Z2 is €7.90 and 52 week low is €2.32.
When is next earnings date of Alector Inc(STU:0Z2)?
The next earnings date of Alector Inc(STU:0Z2) is 2025-02-27 Est..
Does Alector Inc(STU:0Z2) pay dividends? If so, how much?
Alector Inc(STU:0Z2) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers